Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
CRISPR Therapeutics AG (CRSP)
Sector: Healthcare; Industry: Biotechnology

CRISPR Therapeutics AG, a gene editing company, focuses on developing transformative gene-based medicines for serious human diseases. The company's lead product candidate is CTX001, an ex vivo CRISPR gene-edited therapy for treating patients suffering from transfusion-dependent beta thalassemia or severe sickle cell disease in which a patient's hematopoietic stem cells are engineered to produce high levels of fetal hemoglobin in red blood cells. Further, it engages in developing regenerative medicine programs in diabetes; and in vivo and other genetic disease programs to treat glycogen storage disease Ia, Duchenne muscular dystrophy, and cystic fibrosis. The company has strategic partnerships with Bayer Healthcare LLC, Vertex Pharmaceuticals Incorporated, and ViaCyte, Inc. CRISPR Therapeutics AG is headquartered in Zug, Switzerland.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-02-19 Bolzon Bradley J PhD Director Sell 171,003 $149.11 $25,497,840 No
2021-01-15 Kulkarni Samarth Chief Executive Officer Sell 20,000 $213.67 $4,273,311 Yes
2021-01-15 Klein Lawrence Otto CBO & COO Sell 25,000 $215.20 $5,379,940 Yes
2021-01-19 KASINGER JAMES R. General Counsel and Secretary Sell 27,500 $204.94 $5,635,944 Yes
2020-12-21 Ho Tony W Executive VP, Head of R&D Sell 23,551 $149.23 $3,514,610 Yes
2020-12-16 Bolzon Bradley J PhD Director Sell 15,000 $148.95 $2,234,266 No
2020-12-10 Bolzon Bradley J PhD Director Sell 33,000 $143.35 $4,730,448 No
2020-12-10 Bolzon Bradley J PhD Director Sell 33,000 $143.35 $4,730,448 No
2020-12-10 Kulkarni Samarth Chief Executive Officer Sell 20,000 $142.29 $2,845,782 Yes
2020-12-07 Bolzon Bradley J PhD Director Sell 171,004 $154.53 $26,424,505 No
2020-11-30 Novak Rodger President Sell 100,000 $125.00 $12,500,000 Yes
2020-10-09 Novak Rodger President Sell 25,000 $100.00 $2,500,000 Yes
2020-09-18 Bolzon Bradley J PhD Director Sell 3,035 $86.87 $263,636 No
2020-09-16 Bolzon Bradley J PhD Director Sell 8,965 $86.98 $779,777 No
2020-09-14 Bolzon Bradley J PhD Director Sell 1,155 $84.89 $98,045 No
2020-09-10 Bolzon Bradley J PhD Director Sell 22,845 $85.36 $1,949,996 No
2020-09-01 Bolzon Bradley J PhD Director Sell 60,000 $92.51 $5,550,644 Yes
2020-09-01 TOMSICEK MICHAEL JOHN Chief Financial Officer Sell 12,000 $92.26 $1,107,068 Yes
2020-09-01 Novak Rodger President Sell 25,000 $92.62 $2,315,578 Yes
2020-08-19 Novak Rodger President Sell 25,000 $100.00 $2,500,000 Yes
2020-08-03 TOMSICEK MICHAEL JOHN Chief Financial Officer Sell 12,000 $86.74 $1,040,919 Yes
2020-07-07 Novak Rodger President Sell 25,000 $90.00 $2,250,000 Yes
2020-07-06 Bolzon Bradley J PhD Director Sell 20,000 $82.39 $1,647,730 No
2020-07-01 Novak Rodger President Sell 50,000 $80.00 $4,000,000 No
2020-06-25 Klein Lawrence Otto CBO & COO Sell 70,000 $75.88 $5,311,564 Yes
2020-06-23 Novak Rodger President Sell 50,000 $75.00 $3,750,000 No
2020-06-23 Bolzon Bradley J PhD Director Sell 20,000 $73.93 $1,478,522 No
2020-06-23 Ho Tony W Executive VP, Head of R&D Sell 7,158 $75.04 $537,123 No
2020-06-02 Kulkarni Samarth Chief Executive Officer Sell 17,275 $64.68 $1,117,266 Yes
2020-05-26 Novak Rodger President Sell 50,000 $70.20 $3,510,020 No

Insider Smart

Delta Airlines (DAL) - From an insider's perspective: airlines are the first ones to go under due to the pandemic. A lot of concerns were raised on possible bankruptcy especially amid by the dump from Buffett. However, insiders of Delta were bold enough to buy when Buffett was fear. And Delta is the only airline bought by insiders post-Buffett-dump.

Insider Smart

Planet Fitness, Inc (PLNT) - Our position in PLNT is also inspired by insider trading, if insiders are comfortable and confident buying around $50, it is an easy hold if you can pick it up at an even lower price. Our avg cost of the position is ~$40 and is now with 50% profit.